TA-8995 free base · Synonyms: Obicetrapib | AMG-899
Obicetrapib is an orally active cholesteryl ester transfer protein inhibitor.
For research use only. Not for human or veterinary use.
TA-8995 structure
CAS No.: 866399-87-3
Pack sizes & pricing
| Size | Price | SKU | Stock | |
|---|---|---|---|---|
| 50 mg | USD 460.00 | BP-02092-50mg | In stock | Get quote |
| 100 mg | USD 736.00 | BP-02092-100mg | In stock | Get quote |
| 250 mg | USD 1,470.00 | BP-02092-250mg | In stock | Get quote |
| 500 mg | USD 2,360.00 | BP-02092-500mg | In stock | Get quote |
| 1 g | USD 3,770.00 | BP-02092-1g | In stock | Get quote |
| 2 g | USD 6,030.00 | BP-02092-2g | In stock | Get quote |
Need another size or custom synthesis? Request a quote.
Description
Obicetrapib (TA-8995; DEZ-001) is an orally active cholesteryl ester transfer protein (CETP) inhibitor. Obicetrapib potently reduces atherogenic lipoproteins (such as LDL-C, ApoB, Lp (a)) and increases HDL-C. Obicetrapib can be used for the research of dyslipidemia and atherosclerotic cardiovascular disease (ASCVD).
Biological activity
In Vitro Obicetrapib is a weak inducer of CYP3A4, but it has no significant effect on P-gp activity, and has good safety and tolerability.
Identifiers
- SMILES
-
FC(F)(F)C1=CC(C(F)(F)F)=CC(CN(C2=NC=C(OCCCC(O)=O)C=N2)[C@@H]3C4=CC(C(F)(F)F)=CC=C4N([C@@H](C3)CC)C(OCC)=O)=C1 - InChIKey
-
NRWORBQAOQVYBJ-GJZUVCINSA-N
Specifications
- MW (average)
- 722.5980
- Formula
- C32H31F9N4O5
- CAS No.
- 866399-87-3
- Physical state
- Solid
- Color
- white to light yellow
- Shipping
- Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
- Storage
- Powder 4℃ 2 years ; -20℃ 3 years ; In solvent -20℃ 1 month;
Solubility
Soluble in DMSO ≥ 100 mg/mL
Documents
References
Same target
Search CETP- BP-00840 Lp(a)-IN-5 free base · >98%
- BP-01449 ACT-1016-0707 free base · >98%
- BP-01832 GSK-2018682 free base · >98%
- BP-01862 Ozanimod free base · >99%
- BP-01982 BMS-986278 free base · >98%
- BP-02020 Inaxaplin free base · >98%
- BP-02021 APOL1-IN-1 free base · >98%
- BP-02282A Lp(a)-IN-5 hydrochloride salt · >98%
Same research area
Search Cardiovascular Disease- BP-00963 Ulacamten free base · >98%
- BP-01825 Vorolanib free base · >98%
- BP-01836 Carcainium chloride free base · >98%
- BP-01847 CDDO-dhTFEA free base · >98%
- BP-01852 DMH-1 free base · >98%
- BP-01884 Runcaciguat free base · >98%
- BP-01911 Praliciguat free base · >98%
- BP-01912 Olinciguat free base · >98%